Johannes Kleemann

Frankfurt Am Main, HE 60629, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

Journal: Current oncology (Toronto, Ont.)

Published: February 26, 2026

Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphoma.

Targeting the G-protein-coupled estrogen receptor: a novel therapeutic strategy in cutaneous T-cell lymphoma.

Journal: Blood neoplasia

Published: October 28, 2025

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Journal: Journal for immunotherapy of cancer

Published: September 03, 2025

HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs.

HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs.

Journal: Dermatology and therapy

Published: August 02, 2025

Lethal medical course of an untreated giant cutaneous squamous cell carcinoma.

Lethal medical course of an untreated giant cutaneous squamous cell carcinoma.

Journal: Forensic science, medicine, and pathology

Published: July 30, 2025

Neoadjuvant therapy in skin cancer: current evidence and future perspectives.

Neoadjuvant therapy in skin cancer: current evidence and future perspectives.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: March 03, 2025

Deviations from the Porter-Thomas Distribution due to Nonstatistical γ Decay below the ^{150}Nd Neutron Separation Threshold.

Deviations from the Porter-Thomas Distribution due to Nonstatistical γ Decay below the ^{150}Nd Neutron Separation Threshold.

Journal: Physical review letters

Published: January 01, 2025

Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study.

Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: October 30, 2024

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma.

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma.

Journal: Blood advances

Published: October 21, 2024

Exploring the Thoughts, Needs and Fears of Chemotherapy Patients-An Analysis Based on Google Search Behavior.

Exploring the Thoughts, Needs and Fears of Chemotherapy Patients-An Analysis Based on Google Search Behavior.

Journal: Healthcare (Basel, Switzerland)

Published: July 16, 2024

Gamma Decay of the ^{154}Sm Isovector Giant Dipole Resonance: Smekal-Raman Scattering as a Novel Probe of Nuclear Ground-State Deformation.

Gamma Decay of the ^{154}Sm Isovector Giant Dipole Resonance: Smekal-Raman Scattering as a Novel Probe of Nuclear Ground-State Deformation.

Journal: Physical review letters

Published: July 01, 2024

Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma research.

Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma research.

Journal: The British journal of dermatology

Published: June 27, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026